Valuation: Alembic Pharmaceuticals Limited

Market Cap 163B 1.71B 1.48B 1.38B 1.27B 2.39B 2.43B 16.25B 6.38B 81.78B 6.44B 6.3B 270B P/E 2027 *
22.5x
P/E 2028 * 17.3x
Enterprise Value 174B 1.82B 1.58B 1.47B 1.35B 2.54B 2.58B 17.29B 6.79B 87.02B 6.85B 6.7B 288B EV / Sales 2027 *
2.06x
EV / Sales 2028 * 1.72x
Free-Float
29.33%
Yield 2027 *
1.55%
Yield 2028 * 1.69%
1 day-0.52%
1 week+4.15%
Current month+4.15%
1 month+2.32%
3 months+5.47%
6 months+4.07%
Current year-1.90%
1 week 792.55
Extreme 792.55
851.85
1 month 787.4
Extreme 787.4
855.4
Current year 635.8
Extreme 635.8
855.4
1 year 635.8
Extreme 635.8
1,002
3 years 635.8
Extreme 635.8
1,303.9
5 years 462.3
Extreme 462.3
1,303.9
10 years 414.4
Extreme 414.4
1,303.9
Manager TitleAgeSince
Director of Finance/CFO - 07/07/2025
Chief Tech/Sci/R&D Officer - 01/07/2023
Chief Operating Officer - 21/07/2025
Director TitleAgeSince
Chairman 78 08/06/2012
Director/Board Member 50 01/01/2007
Director/Board Member 66 18/01/2003
Date Insider Type Main position Quantity % Market Cap.
28/03/25
Nirayu Pvt Ltd.
BuyCompany 12,665 0.0064%
24/03/25
Nirayu Pvt Ltd.
BuyCompany 7,600 0.0039%
21/03/25 Buy 2,000 0.0010%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+4.15%-11.33%+4.94% 1.71B
-0.52%+3.21%+89.52%+127.32% 1,057B
+0.88%+1.13%+49.56%+49.69% 625B
+0.89%-1.95%+24.23%+64.44% 435B
+0.71%+3.87%+49.07%+37.85% 363B
+0.64%-0.49%+33.94%+40.01% 296B
+0.39%-5.83%+8.92%+7.85% 249B
+1.51%+6.69%+42.58%+57.57% 222B
+3.92%-0.46%-5.56%-52.32% 209B
+1.80%+2.30%+11.56%+66.35% 165B
Average +0.97%+1.19%+29.25%+40.37% 362.25B
Weighted average by Cap. +0.66%+1.22%+48.69%+64.60%

Financials

2027 *2028 *
Net sales 84.17B 884M 765M 714M 655M 1.23B 1.25B 8.38B 3.29B 42.19B 3.32B 3.25B 139B 92.45B 971M 840M 785M 720M 1.35B 1.38B 9.21B 3.61B 46.34B 3.65B 3.57B 153B
Net income 7.32B 76.9M 66.52M 62.12M 56.99M 107M 109M 729M 286M 3.67B 289M 282M 12.13B 9.48B 99.57M 86.13M 80.43M 73.79M 139M 141M 944M 370M 4.75B 374M 366M 15.7B
Net Debt 10.45B 110M 94.98M 88.7M 81.37M 153M 155M 1.04B 408M 5.24B 412M 403M 17.32B -4.24B -44.58M -38.56M -36.01M -33.04M -62.14M -63.12M -423M -166M -2.13B -167M -164M -7.03B
Logo Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.
Employees
17,244
Date Price Change Volume
07/08/26 ₹830.10 -0.52% 156,108
06/08/26 ₹834.45 +1.99% 210,314
05/08/26 ₹818.20 +1.09% 243,621
04/08/26 ₹809.40 +0.45% 485,095
03/08/26 ₹805.75 +1.09% 58,590
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
830.10INR
Average target price
949.30INR
Spread / Average Target
+14.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. APLLTD Stock